Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Akcea Therapeutics
Akcea Therapeutics
(AKCA)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Tegsedi
Inotersen
2018-10-05
2025-2031
Amyloidosis
,
Familial amyloid neuropathies
Waylivra
Volanesorsen
2019-05-03
Hyperlipoproteinemia type i
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Volanesorsen
cardiovascular abnormalities
,
hyperlipoproteinemia type i
,
syndrome
,
hyperlipidemias
,
hyperlipoproteinemia type v
,
hyperlipoproteinemias
,
lipodystrophy
,
familial partial lipodystrophy
,
hypertriglyceridemia
Inotersen
amyloidosis
,
familial amyloid neuropathies
,
pregnancy
Sodium chloride
graft rejection
Nepidermin
carcinoma
,
triple negative breast neoplasms
,
squamous cell carcinoma of head and neck
,
neoplasms
,
colorectal neoplasms
,
breast neoplasms
,
ovarian neoplasms
,
pancreatic ductal carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
adenocarcinoma
,
squamous cell carcinoma
,
biliary tract neoplasms
,
esophageal squamous cell carcinoma
,
ovarian epithelial carcinoma
,
glioblastoma
,
non-small-cell lung carcinoma
,
gliosarcoma
,
lung neoplasms
Pelacarsen
renal insufficiency
,
healthy volunteers/patients
,
cardiovascular diseases
,
hyperlipidemias
,
hyperlipoproteinemias
VUPANORSEN
hypertriglyceridemia
,
hypercholesterolemia
,
hyperlipoproteinemia type ii
,
lipodystrophy
,
familial partial lipodystrophy
,
liver diseases
,
type 2 diabetes mellitus
,
diabetes mellitus
,
non-alcoholic fatty liver disease
,
fatty liver
,
hyperlipidemias
,
hyperlipoproteinemia type v
,
syndrome
,
hyperlipoproteinemia type i
,
hyperlipoproteinemias
,
homozygous familial hypercholesterolemia
Endocrine
hypogonadism
Trinessa
healthy volunteers/patients
,
chronic obstructive pulmonary disease
,
obstructive lung diseases
,
infections
,
communicable diseases
,
infectious skin diseases
,
bacterial skin diseases
,
skin diseases
,
endophthalmitis
Tqj230
healthy volunteers/patients
,
cardiovascular diseases
,
hyperlipidemias
,
hyperlipoproteinemias
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use